SanFrancisco,CA., November 22, 2013 – The human eye is one of the most complex systems of our body. From taking in the world and light around to projecting those images onto our retina and then transporting that image to our brain all in a matter of nanoseconds, our visual systems are a wonder. But with the complexity, also comes difficulties in assessing the health of that system.
City Optometry, of Lower Nob Hill, understands this complexity but also the needs to fully assess their patients full visual system health. To do so, the practice announced today the addition of the Diopsys® NOVA-VEP Vision Testing System, a new vision testing system that helps eye care professionals detect vision deficits, including glaucoma and other neuro-visual disorders.
Glaucoma is the second leading cause of blindness in the world, reports the World Health Organization. According to Prevent Blindness America, glaucoma is often called the "sneak thief of sight" because half of all patients who have it do not know it. Many optic nerve disorders are asymptomatic, meaning they do not immediately affect a patient’s sight and therefore remain undetected. Central vision may not be affected until later stages of the disease. Also, diagnosis and management of optic nerve disorders are often based on structural or visual field tests which are limited in their ability to detect disease early.
The Diopsys® NOVA-VEP is allowing the clinicians at City Optometry to objectively assess vision disorders earlier than traditional vision tests because it uses Visual Evoked Potential (VEP) technology and proprietary software to evaluate the entire vision system from the eye to the visual cortex. “This will allow our optometrists to provide an earlier and more accurate diagnosis of a variety of serious problems for our patient,” reported Dr. Vincent Penza of City Optometry. “Utilizing VEP is in keeping with our commitment to bring our community the most advance technologies available in eye care.”
The Diopsys® NOVA-VEP records the electrical response of a patient’s entire vision system and provides easy-to-read reports that give the doctor a comprehensive way to evaluate optic nerve function. Clinicians are able to compare tests over time to track disease progression and evaluate interventions provided.
“With regards to glaucoma, we are encouraging adults over the age of forty-five to come in for this test and an evaluation,” stated Dr. Penza. “This is the case of an ounce of prevention far outweighs a pound of cure. Your eyes are irreplaceable and if well cared for, they can serve you well for your entire life.”
City Optometry is located on 530 Bush Street, Suite 101 in San Francisco and serves the entire downtown San Francisco area. Dr. Vincent Penza has been serving the San Francisco community as their eye care professional for over 20 years. Dr. Penza is a member of the Board of Directors, California Optometric Laser Associates, Inc.